MS vs SNEX: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

MS is the larger of the two ($292.45B market cap): the incumbent the market prices for continued execution (13.69x forward earnings, beta 1.22). SNEX is the smaller challenger ($6.80B), priced similarly on forward earnings (11.93x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

MS vs SNEX: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricMSSNEXWhat it tells you
Market cap$292.45B$6.80BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E13.6911.93Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E14.8418.68Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta1.220.63Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range43% of range34% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book2.732.38How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Before you buy: how MS and SNEX affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MS and SNEX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MS and SNEX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Morgan Stanley (MS) do?

Morgan Stanley is a global financial services firm founded in 1935 and headquartered in New York City, with offices in 42 countries and more than 80,000 employees. It operates through three segments: Institutional Securities (investment banking, equity and fixed-income trading, prime brokerage, and research), Wealth Management (financial-advisor-led brokerage, investment advisory, lending, and banking services for individuals and families), and Investment Management (equity, fixed income, alternatives, and liquidity strategies for institutions and intermediaries). The firm earns revenue through advisory and underwriting fees, trading gains, and, increasingly, recurring asset-based fees tied to the value of client assets across its wealth and investment management platforms. The current Morgan Stanley took its modern shape through the 1997 merger with Dean Witter Discover and a string of subsequent acquisitions, most notably E*TRADE (2020) and Eaton Vance (2021), which dramatically expanded its self-directed brokerage and asset management capabilities. Ted Pick became Chairman and CEO at the start of 2024, succeeding James Gorman, who had led the firm since 2010 and orchestrated its transformation toward fee-based businesses. Under Pick, the integrated-firm strategy emphasizes cross-selling across all three segments and driving client assets toward fee-based relationships to generate more predictable earnings.

Full MS guide

What does StoneX Group (SNEX) do?

StoneX Group Inc. is a New York-headquartered financial-services firm that stands as a middleman between clients and the world's financial and commodity markets. It serves more than 54,000 commercial, institutional, and global-payments clients plus over 400,000 retail accounts across roughly 80 offices on five continents, organizing its work into four segments: Commercial (agricultural, energy, and metals hedging), Institutional (securities, futures, FX, and prime services), Retail (self-directed trading brands), and Global Payments (cross-border money movement into hard-to-reach currencies). Because much of what StoneX does is regulated brokerage, clearing, and market-making, the company operates as a holding company over many licensed subsidiaries. A defining recent move was the roughly $900 million acquisition of futures broker R.J. O'Brien, which closed on July 31, 2025 and made StoneX the largest non-bank futures commission merchant in the United States, adding tens of thousands of clients and billions in client float.

Full SNEX guide

MS vs SNEX: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • MS drivers: Wealth management as a recurring-revenue engine; Capital-markets cycle recovery.
  • SNEX drivers: Scale from the R.J. O'Brien deal; Interest income on client float.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. For SNEX, stoneX operates in a low-margin, capital-intensive, and highly regulated industry where a single operational, credit, or compliance failure at any of its many subsidiaries can be costly.

MS or SNEX: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MS if you believe its drivers more; SNEX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MS and SNEX guides.

MS vs SNEX: the full fundamentals

MS. Morgan Stanley's trailing P/E has compressed from roughly 19 to 20 times in June 2026 to ~14.5 times, because earnings kept rising while the share price slid to ~$183. That puts the stock back near its own 5-year historical average of around 14 to 15 times, after a year in which it traded at a premium. Analysts' mean target of ~$213 (22 analysts) sits above the current price, while consensus expects EPS growth to slow to ~6% in 2027, which is the main reason the market is paying less for each dollar of earnings.

SNEX. StoneX has grown earnings sharply in fiscal 2026 as the RJO acquisition, client float and active markets fed through, and every quarter in the past year beat estimates. Note the revenue distinction: the firm reports well over $100 billion of gross transactional revenue that is largely pass-through cost, so net income and operating revenues are the more meaningful figures, and margins on the gross line (~0.3% net) say little. At ~$57.74, after two 3-for-2 splits in 2026, the stock trades around 19 times trailing and 12 times forward earnings, cheaper than earlier in the year after a ~23% three-month pullback.

Headline figures (approximate, October 2026): MS shows revenue (ttm, through q3 2026) ~$79.8 billion, revenue growth (q3 2026, yoy) ~11%, net income (ttm) ~$19.9 billion, eps (ttm) ~$12.61; SNEX shows gross revenue (ttm) ~$155.8B, up ~15.2% YoY in the latest quarter (mostly pass-through physical commodity sales), net income (ttm) ~$510M (vs ~$306M in FY2025), latest quarter (june 2026) Net income ~$128M; EPS $1.04 vs ~$0.82 consensus, eps (trailing / fy2026 consensus) ~$3.02 / ~$4.63 (post-split basis).

The bottom line: MS vs SNEX

MS and SNEX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MS and SNEX exposure against your real portfolio. It is not an investment adviser.

Wondering how MS or SNEX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Morgan Stanley

Ask Walnut's AI anything about MS and see how it fits what you own.

FAQ

What is the difference between MS and SNEX?

+

Morgan Stanley is a global financial services firm founded in 1935 and headquartered in New York City, with offices in 42 countries and more than 80,000 employees. StoneX Group Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is MS or SNEX the better stock?

+

Neither is universally better. MS is the larger incumbent; SNEX is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, MS or SNEX?

+

On forward P/E (as of November 2026), MS trades at 13.69x and SNEX at 11.93x, so SNEX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both MS and SNEX?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of MS vs SNEX?

+

MS: A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. Regulatory capital requirements remain an ongoing headwind, with Basel-related rules potentially requiring the firm to hold more capital against trading and lending exposures, constraining returns. Morgan Stanley's stock also carries a beta above 1.0, meaning it tends to move more than the broader market in both directions, so sharp equity-market selloffs can produce outsized drawdowns. Finally, a structural decline in equity underwriting volumes over a prolonged period would disproportionately affect a firm that has historically ranked as a top equity underwriter globally. The 2026 price action shows a further risk: strong reported results do not guarantee a rising share price once growth is expected to slow. MS fell ~15% over the three months to mid-October 2026 despite beating EPS estimates in every quarter of the year. SNEX: StoneX operates in a low-margin, capital-intensive, and highly regulated industry where a single operational, credit, or compliance failure at any of its many subsidiaries can be costly. Earnings are cyclical and depend on volatility, trading volumes, and interest rates, so a calm market or falling rates can pressure results. The acquisition-heavy strategy carries integration and leverage risk, and the RJO deal added debt and execution demands. As an intermediary the firm is exposed to counterparty and client-credit risk, and its very large gross-revenue figures can obscure the thinner underlying economics, which makes the stock prone to sharp swings, as its wide 52-week trading range shows. The stock fell ~23% over the three months to October 16, 2026 and ~14% in the past month, and a string of insider share sales was disclosed in SEC filings in late September and October 2026. Fiscal fourth-quarter results are expected around November 23, 2026, with consensus EPS of ~$0.92, below the ~$1.04 earned in the June quarter.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell MS or SNEX; figures are approximate and dated (as of November 2026). Verify current data before investing.